New Alternatives for Autoimmune Disease Treatments: Physicochemical and Clinical Comparability of Biosimilar Etanercept

Etanercept is a recombinant fusion protein approved for the treatment of TNF-α mediated diseases such as rheumatoid arthritis (RA), psoriasis, psoriatic arthritis, and ankylosing spondylitis. Herein, we present an evaluation of the physicochemical and biological properties of a biosimilar etanercept...

Descripción completa

Detalles Bibliográficos
Autores principales: Miranda-Hernández, Mariana P., López-Morales, Carlos A., Perdomo-Abúndez, Francisco C., Salazar-Flores, Rodolfo D., Ramírez-Ibanez, Nancy D., Pérez, Nestor O., Molina-Pérez, Aarón, Revilla-Beltri, Jorge, Flores-Ortiz, Luis F., Medina-Rivero, Emilio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2016
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4921158/
https://www.ncbi.nlm.nih.gov/pubmed/27382576
http://dx.doi.org/10.1155/2016/9697080

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4921158/
https://www.ncbi.nlm.nih.gov/pubmed/27382576
http://dx.doi.org/10.1155/2016/9697080

Ejemplares similares